Holen Sie sich die Stockscreener-App
0.1726
5.63%
0.0092
Vorhandelsmarkt:
.13
-0.0426
-24.68%
Schlusskurs vom Vortag:
$0.1634
Offen:
$0.163
24-Stunden-Volumen:
8.16M
Relative Volume:
4.51
Marktkapitalisierung:
$39.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-67.01M
KGV:
-0.5076
EPS:
-0.34
Netto-Cashflow:
$-8.50M
1W Leistung:
+4.67%
1M Leistung:
-27.78%
6M Leistung:
-75.98%
1J Leistung:
-64.23%
1-Tages-Spanne:
$0.1622
$0.176
1-Wochen-Bereich:
$0.155
$0.192
52-Wochen-Spanne:
$0.155
$2.10
Lunai Bioworks Inc Stock (RENB) Company Profile
Firmenname
Lunai Bioworks Inc
Sektor
Branche
Telefon
45 39179840
Adresse
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Vergleichen Sie RENB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RENB
Lunai Bioworks Inc
|
0.1726 | 37.73M | 0 | -67.01M | -8.50M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Lunai Bioworks Inc Aktie (RENB) Neueste Nachrichten
Lunai Bioworks To Carry Out 1-for-10 Reverse Stock Split On September 30th, 2025 - 富途牛牛
Lunai Bioworks to Implement 10-for-1 Reverse Stock Split; Shares Slump After Hours - MarketScreener
Lunai Bioworks to implement 10:1 reverse stock split - TipRanks
Lunai Bioworks to effect 10:1 reverse stock split - MSN
Lunai Bioworks stock plunges after announcing 10:1 reverse split By Investing.com - Investing.com UK
Lunai Bioworks stock plunges after announcing 10:1 reverse split - Investing.com
231.7M Shares to Become 23.1M: Lunai Bioworks Implements Major Reverse Stock Split for Nasdaq Listing - Stock Titan
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split - The Globe and Mail
Stocks Moving Premarket: GLTO, SSKN, QLGN, And Other Gainers & Losers - RTTNews
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - Gadsden Times
$1.85M NIH Grant Powers Lunai Bioworks' AI Platform to Combat Alcohol Disorder Affecting 19M Americans - Stock Titan
Lunai Bioworks launches transformer-base platform to secure GenAI - The Globe and Mail
Top 3 Health Care Stocks You'll Regret Missing In Q3 - Sahm
REN-B: Lunai Bioworks Unveils AI Platform to Ensure Biological S - GuruFocus
First-Ever AI Safety Platform: Lunai Bioworks Launches Transformer Tech to Secure Drug Discovery & Block Biothreat - Stock Titan
GoodData Acquires Understand Labs, Accelerates AI Data Storytelling and Agentic Vision - Bergen Record
1933 Industries Closes Repurchase and Cancellation of Convertible Debentures - azcentral.com and The Arizona Republic
Lunai Bioworks (RENB) Restructures European Operations for Strat - GuruFocus
Lunai Bioworks Strengthens European Strategy Through Restructuring - PharmiWeb.com
Lunai Bioworks Strengthens European Strategy Through Restructuri - GuruFocus
Lunai Bioworks strengthens European strategy through restructuring - TipRanks
AI Drug Discovery Firm Lunai Bioworks Restructures European Business, Maintains Growth Strategy - Stock Titan
Lunai Bioworks subsidiary Gedi Cube B.V. files for bankruptcy in Amsterdam - Investing.com Australia
Renovaro Biosciences Faces Subsidiary Bankruptcy Impact - TipRanks
Lunai Bioworks subsidiary Gedi Cube B.V. files for bankruptcy in Amsterdam By Investing.com - Investing.com South Africa
Renovaro Inc. shares fall 13.53% after-hours following Lunai Bioworks IncGedi Cube B.V. bankruptcy. - AInvest
Lunai Bioworks IncGedi Cube B.V. Declared Bankrupt By Court Of AmsterdamSEC Filing - TradingView
Lunai partners with defense firm to develop chemical weapons countermeasures - Investing.com Australia
Lunai Bioworks Inc. Retains American Defense International | RENB Stock News - GuruFocus
Lunai Bioworks Inc. Retains American Defense International - PharmiWeb.com
Renovaro BioSciences to change corporate name to ‘Lunai Bioworks’ - MSN
Order flow analysis tools used on Renovaro Inc.July 2025 Selloffs & Verified Entry Point Detection - Newser
Published on: 2025-08-28 20:54:17 - Newser
Applying Elliott Wave Theory to Renovaro Inc.2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
Chart overlay techniques for tracking Renovaro Inc.Weekly Trade Analysis & Risk Controlled Swing Alerts - Newser
Will Renovaro Inc. stock go up soonWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
What earnings revisions data tells us about Renovaro Inc.Trade Performance Summary & Growth Focused Entry Point Reports - Newser
Quantitative breakdown of Renovaro Inc. recent moveIPO Watch & Expert Curated Trade Ideas - Newser
Evaluating Renovaro Inc. with trendline analysisJuly 2025 Fed Impact & Stock Portfolio Risk Management - Newser
Applying Wyckoff theory to Renovaro Inc. stockJuly 2025 Drop Watch & Capital Protection Trading Alerts - Newser
Finanzdaten der Lunai Bioworks Inc-Aktie (RENB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.30%
2.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):